A longitudinal study tracking 47 convalescent individuals reported sustained immune dysregulation up to three years after COVID-19 infection. The study linked prolonged inflammation to impaired recovery of multiple T-cell compartments, with Th17 subsets implicated in inflammation beyond one year. Th17 dynamics diverged functionally, and one subset correlated with patient-reported long COVID symptoms. The work also described persistent elevation of inflammatory mediators S100A8 and interleukin-16 over the follow-up period, supporting that immune remodeling does not fully resolve for some patients.
Get the Daily Brief